Patients with osteosarcoma and soft tissue sarcoma might become “cancer refugees” in some japanese regional cities

Hiromichi Yamane, Toshiyuki Kunisada, Toshihumi Ozaki, Nobuaki Ochi, Yoshihiro Honda, Yasunari Nagasaki, Nozomu Nakagawa, Tomoko Yamagishi, Hidekazu Nakanishi, Nagio Takigawa

Research output: Contribution to journalArticle

Abstract

Purpose: “Rare cancer” is defined as malignancy with a disease prevalence (age-adjusted incidence rate) of less than six per 100,000 population. Proper treatments which these patients need cannot always be performed unless they find dedicated facilities. Patients tend to be desperate, searching for advice and care. Thus, they are called “cancer refugees”. Osteosarcoma and soft tissue sarcoma (OS/STS) are representative rare cancers in Japan. We conducted a retrospective analysis of patients with OS/STS to improve the current treatment modalities in a Japanese regional city. Patients and methods: Twenty-one patients with OS/STS who were hospitalized to receive standard chemotherapy or palliative treatment were enrolled between October 2011 and January 2017. Patients with non-Hodgkin’s lymphoma (NHL) and advanced cancer who were treated in the palliative care unit (PCU) of the Kawasaki Medical School General Medical Center were recruited as the control groups. We analyzed the difference in residential area between patients with OS/STS and the control groups. Results: Approximately one-third of patients with OS/STS were referred from hospitals outside of Okayama prefecture. The ratio of patients with OS/STS referred from Okayama city and/or the same medical administration area of Okayama prefecture was lower than that of patients with NHL and advanced cancer who were treated in the PCU. Conclusion: Because the medical environment of patients with OS/STS in Japanese local cities has not been consolidated, completing medical care within the patient’s own medical administration area is difficult. Thus, some patients with OS/STS may become “cancer refugees” who are unable to receive standard therapy near their residence.

Original languageEnglish
Pages (from-to)353-359
Number of pages7
JournalCancer Management and Research
Volume10
DOIs
Publication statusPublished - Feb 19 2018

Fingerprint

Refugees
Osteosarcoma
Sarcoma
Neoplasms
Palliative Care
Non-Hodgkin's Lymphoma
Control Groups
Medical Schools
Patient Care
Japan
Therapeutics

Keywords

  • Cancer refugee
  • Osteosarcoma
  • Rare cancer
  • Soft tissue sarcoma

ASJC Scopus subject areas

  • Oncology

Cite this

Patients with osteosarcoma and soft tissue sarcoma might become “cancer refugees” in some japanese regional cities. / Yamane, Hiromichi; Kunisada, Toshiyuki; Ozaki, Toshihumi; Ochi, Nobuaki; Honda, Yoshihiro; Nagasaki, Yasunari; Nakagawa, Nozomu; Yamagishi, Tomoko; Nakanishi, Hidekazu; Takigawa, Nagio.

In: Cancer Management and Research, Vol. 10, 19.02.2018, p. 353-359.

Research output: Contribution to journalArticle

Yamane, Hiromichi ; Kunisada, Toshiyuki ; Ozaki, Toshihumi ; Ochi, Nobuaki ; Honda, Yoshihiro ; Nagasaki, Yasunari ; Nakagawa, Nozomu ; Yamagishi, Tomoko ; Nakanishi, Hidekazu ; Takigawa, Nagio. / Patients with osteosarcoma and soft tissue sarcoma might become “cancer refugees” in some japanese regional cities. In: Cancer Management and Research. 2018 ; Vol. 10. pp. 353-359.
@article{3105dec6eafe4c729ef204af0808e259,
title = "Patients with osteosarcoma and soft tissue sarcoma might become “cancer refugees” in some japanese regional cities",
abstract = "Purpose: “Rare cancer” is defined as malignancy with a disease prevalence (age-adjusted incidence rate) of less than six per 100,000 population. Proper treatments which these patients need cannot always be performed unless they find dedicated facilities. Patients tend to be desperate, searching for advice and care. Thus, they are called “cancer refugees”. Osteosarcoma and soft tissue sarcoma (OS/STS) are representative rare cancers in Japan. We conducted a retrospective analysis of patients with OS/STS to improve the current treatment modalities in a Japanese regional city. Patients and methods: Twenty-one patients with OS/STS who were hospitalized to receive standard chemotherapy or palliative treatment were enrolled between October 2011 and January 2017. Patients with non-Hodgkin’s lymphoma (NHL) and advanced cancer who were treated in the palliative care unit (PCU) of the Kawasaki Medical School General Medical Center were recruited as the control groups. We analyzed the difference in residential area between patients with OS/STS and the control groups. Results: Approximately one-third of patients with OS/STS were referred from hospitals outside of Okayama prefecture. The ratio of patients with OS/STS referred from Okayama city and/or the same medical administration area of Okayama prefecture was lower than that of patients with NHL and advanced cancer who were treated in the PCU. Conclusion: Because the medical environment of patients with OS/STS in Japanese local cities has not been consolidated, completing medical care within the patient’s own medical administration area is difficult. Thus, some patients with OS/STS may become “cancer refugees” who are unable to receive standard therapy near their residence.",
keywords = "Cancer refugee, Osteosarcoma, Rare cancer, Soft tissue sarcoma",
author = "Hiromichi Yamane and Toshiyuki Kunisada and Toshihumi Ozaki and Nobuaki Ochi and Yoshihiro Honda and Yasunari Nagasaki and Nozomu Nakagawa and Tomoko Yamagishi and Hidekazu Nakanishi and Nagio Takigawa",
year = "2018",
month = "2",
day = "19",
doi = "10.2147/CMAR.S155282",
language = "English",
volume = "10",
pages = "353--359",
journal = "Cancer Management and Research",
issn = "1179-1322",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Patients with osteosarcoma and soft tissue sarcoma might become “cancer refugees” in some japanese regional cities

AU - Yamane, Hiromichi

AU - Kunisada, Toshiyuki

AU - Ozaki, Toshihumi

AU - Ochi, Nobuaki

AU - Honda, Yoshihiro

AU - Nagasaki, Yasunari

AU - Nakagawa, Nozomu

AU - Yamagishi, Tomoko

AU - Nakanishi, Hidekazu

AU - Takigawa, Nagio

PY - 2018/2/19

Y1 - 2018/2/19

N2 - Purpose: “Rare cancer” is defined as malignancy with a disease prevalence (age-adjusted incidence rate) of less than six per 100,000 population. Proper treatments which these patients need cannot always be performed unless they find dedicated facilities. Patients tend to be desperate, searching for advice and care. Thus, they are called “cancer refugees”. Osteosarcoma and soft tissue sarcoma (OS/STS) are representative rare cancers in Japan. We conducted a retrospective analysis of patients with OS/STS to improve the current treatment modalities in a Japanese regional city. Patients and methods: Twenty-one patients with OS/STS who were hospitalized to receive standard chemotherapy or palliative treatment were enrolled between October 2011 and January 2017. Patients with non-Hodgkin’s lymphoma (NHL) and advanced cancer who were treated in the palliative care unit (PCU) of the Kawasaki Medical School General Medical Center were recruited as the control groups. We analyzed the difference in residential area between patients with OS/STS and the control groups. Results: Approximately one-third of patients with OS/STS were referred from hospitals outside of Okayama prefecture. The ratio of patients with OS/STS referred from Okayama city and/or the same medical administration area of Okayama prefecture was lower than that of patients with NHL and advanced cancer who were treated in the PCU. Conclusion: Because the medical environment of patients with OS/STS in Japanese local cities has not been consolidated, completing medical care within the patient’s own medical administration area is difficult. Thus, some patients with OS/STS may become “cancer refugees” who are unable to receive standard therapy near their residence.

AB - Purpose: “Rare cancer” is defined as malignancy with a disease prevalence (age-adjusted incidence rate) of less than six per 100,000 population. Proper treatments which these patients need cannot always be performed unless they find dedicated facilities. Patients tend to be desperate, searching for advice and care. Thus, they are called “cancer refugees”. Osteosarcoma and soft tissue sarcoma (OS/STS) are representative rare cancers in Japan. We conducted a retrospective analysis of patients with OS/STS to improve the current treatment modalities in a Japanese regional city. Patients and methods: Twenty-one patients with OS/STS who were hospitalized to receive standard chemotherapy or palliative treatment were enrolled between October 2011 and January 2017. Patients with non-Hodgkin’s lymphoma (NHL) and advanced cancer who were treated in the palliative care unit (PCU) of the Kawasaki Medical School General Medical Center were recruited as the control groups. We analyzed the difference in residential area between patients with OS/STS and the control groups. Results: Approximately one-third of patients with OS/STS were referred from hospitals outside of Okayama prefecture. The ratio of patients with OS/STS referred from Okayama city and/or the same medical administration area of Okayama prefecture was lower than that of patients with NHL and advanced cancer who were treated in the PCU. Conclusion: Because the medical environment of patients with OS/STS in Japanese local cities has not been consolidated, completing medical care within the patient’s own medical administration area is difficult. Thus, some patients with OS/STS may become “cancer refugees” who are unable to receive standard therapy near their residence.

KW - Cancer refugee

KW - Osteosarcoma

KW - Rare cancer

KW - Soft tissue sarcoma

UR - http://www.scopus.com/inward/record.url?scp=85042356844&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042356844&partnerID=8YFLogxK

U2 - 10.2147/CMAR.S155282

DO - 10.2147/CMAR.S155282

M3 - Article

AN - SCOPUS:85042356844

VL - 10

SP - 353

EP - 359

JO - Cancer Management and Research

JF - Cancer Management and Research

SN - 1179-1322

ER -